United States Infectious Disease Molecular Diagnostics Market Report 2015-2019

Jul 13, 2015, 17:59 ET from Research and Markets

DUBLIN, July 13, 2015 /PRNewswire/ --

Dublin - Research and Markets (http://www.researchandmarkets.com/research/5qsbfm/20152019_us) has announced the addition of the "2015-2019 US Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. 

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. 

Report Highlights 

- Business and technological trends in major markets 
- Five-year test volume and sales forecasts 
- Market shares of leading competitors 
- Feature comparison of major analyzers 
- Strategic profiles of leading market players and start-up firms developing innovative products 
- Specific product and business opportunities for instrument and consumable suppliers. 

U.S. Market Overview 

- Laboratories performing DNA sequencing and molecular diagnostic testingfor infectious diseases 

Market segment. 

- Five-year test volume and sales projections. 

Market Segmentation Analysis 

- Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. 
- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. 
- A comprehensive analysis of the sequencing market by country and laboratory segment. 
- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. 

Product/Technology Review 

- Comparison of leading infectious disease molecular diagnosticanalyzers. 
- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. 
- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. 

Competitive Assessments 

- Abbott 
- Affymetrix 
- Agilent Technologies 
- Applied Gene Technologies 
- Arca Biopharma 
- Beckman Coulter/Danaher 
- Becton Dickinson 
- Biokit 
- BioMerieux 
- Bio-Rad 
- Biotest 
- Cepheid 
- CellMark Forensics Lab/Corp 
- Decode Genetics 
- Diadexus 
- Eiken 
- Elitech Group 
- Grifols 
- Hologic/Gen-Probe 
- Illumina 
- Kreatech/Leica 
- Li-Cor Biosciences 
- Monogram Biosciences 
- Myriad Genetics 
- Ortho-Clinical Diagnostics 
- Perkin Elmer/Caliper 
- Proteome Sciences 
- Qiagen 
- Roche 
- Shimadzu 
- Siemens 
- Sierra Molecular 
- Takara Bio 
- Tecan Group 
- Thermo Fisher

For more information visit http://www.researchandmarkets.com/research/5qsbfm/20152019_us

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets